> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# OND 55 Drug Approvals in 2023
- URL: https://www.fdaweb.com/ond-55-drug-approvals-in-2023/
- Published: 2024-04-30T12:00:00.000Z
- Updated: 2026-09-14T14:29:38.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5156886

The CDER Office of New Drugs (OND) says it was involved in 55 novel drug approvals in 2023\. The approvals are one of the OND successes listed in its 2023 [Annual Report](https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDEsInVyaSI6ImJwMjpjbGljayIsInVybCI6Imh0dHBzOi8vd3d3LmZkYS5nb3YvbWVkaWEvMTc4MTExL2Rvd25sb2FkP2F0dGFjaG1lbnQ9JnV0bV9tZWRpdW09ZW1haWwmdXRtX3NvdXJjZT1nb3ZkZWxpdmVyeSIsImJ1bGxldGluX2lkIjoiMjAyNDA0MzAuOTQxMDEwMjEifQ.PKHTJONNQ4AQrHp8RF-04trqe7cSo2x8f2-ASMWmx8o/s/1255931999/br/241623165108-l?ref=fdaweb.com). Other report highlights are:

- 25 public advisory committee meetings;
- over 3,400 formal meetings with drug development program sponsors;
- 34 guidances issued; and
- 651 OND speaking engagements.